![](/img/cover-not-exists.png)
Axitinib with or without dose titration for first-line metastatic renal-cell carcinoma: a randomised double-blind phase 2 trial
Rini, Brian I, Melichar, Bohuslav, Ueda, Takeshi, Grünwald, Viktor, Fishman, Mayer N, Arranz, José A, Bair, Angel H, Pithavala, Yazdi K, Andrews, Glen I, Pavlov, Dmitri, Kim, Sinil, Jonasch, EricVolume:
14
Language:
english
Journal:
The Lancet Oncology
DOI:
10.1016/S1470-2045(13)70464-9
Date:
November, 2013
File:
PDF, 244 KB
english, 2013